Atlas Trials

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

Clinical trial NCT00944372 · TERMINATED

Trial details

NCT number
NCT00944372
Sponsor
Mallinckrodt
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Solid Tumors
Start date
2003-07-01
Primary completion
2005-08-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.